Abstract

There is a lack of studies regarding the long-term outcomes of Asian adults with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. We hypothesized that adults with CAH are at higher metabolic risk than their age-, and sex-matched controls. We further investigated the long-term health outcome-related factors in adults with CAH. We compared metabolic risk between adults with CAH (71 men, 93 women) and age-, and sex-matched controls (190 men, 261 women) from the Korean National Health and Nutrition Examination Survey data. The presence of obesity, testicular adrenal rest tumors (TARTs), and menstrual irregularity was assessed. Hormone status and treatment regimens were compared according to the presence of adverse outcomes. The median age was 27.0 y and 28.0 y for men and women, respectively. Adults with CAH had a higher waist circumference (88.0 vs. 82.3 cm in men, and 83.5 vs. 72.3 cm in women), and blood pressure (125.0 vs. 113.0 mmHg in men, and 120.0 vs. 104.0 mmHg in women) than age- and sex-matched controls (P<0.05 for all). The 2.7-fold increased risk for hypertension (men) and 2.0-fold increased risk for obesity (women) was significant in patients with CAH (P<0.05 for both). Obese adults with CAH showed significantly higher adrenal limb thicknesses (men) and 17-hydroxyprogesterone and dehydroepiandrosterone sulfate levels (women) (P<0.05 for both). TARTs occurred in 58.1% of men and did not differ by hormone or treatment regimen. Irregular menstruation was observed in 57.1% of women, with higher dehydroepiandrosterone sulfate levels in those with irregular periods. Adults with CAH had a higher metabolic risk than the general population. Poor disease control may increase their risk of metabolic morbidity and menstrual irregularity.

Highlights

  • Congenital adrenal hyperplasia (CAH) refers to a group of genetic disorders characterized by defective steroidogenesis due to enzyme deficiency

  • We aimed to investigate sex-specific indicators related to adverse health outcomes by focusing on metabolic morbidity, testicular adrenal rest tumors (TARTs), and menstrual irregularity in adults with CAH

  • Fasting plasma glucose and blood pressure were higher in the men with CAH (P < 0.05), but hemoglobin A1c (HbA1c) was similar between the two groups

Read more

Summary

Introduction

Congenital adrenal hyperplasia (CAH) refers to a group of genetic disorders characterized by defective steroidogenesis due to enzyme deficiency. The most common form of CAH, 21-hydroxylase deficiency, affects approximately 1:15,000 live births [1, 2]. In the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE), 203 adults with CAH were significantly shorter and had a higher body mass index (BMI) compared to the health survey data [3]. In a Swedish study, based on disease codes, 360 adults with CAH had an approximately four-fold higher risk of having any cardiovascular and metabolic disorders than matched controls [4]. In a European multicenter study, 226 adults with CAH were a higher risk for hypertension, dyslipidemia, and cardiovascular disease but not type 2 diabetes [7]. A recent meta-analysis including children and adults with CAH demonstrated that these patients had a high prevalence of cardiovascular and metabolic risk factors [8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call